Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?
· finance.yahoo.com
Parabilis Medicines, a Cambridge, Massachusetts, biotech innovator in oncology, reported a notable insider buy amid ongoing development of cancer therapies.
Parabilis Medicines is a Cambridge, Massachusetts-based biotechnology company specializing in the development of novel cell-penetrating miniproteins for oncolog...